Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,561 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06948942Recruiting
Exercise ability in interstitial lung disease
This study compares exercise capacity, muscle oxygen levels, and physical activity between people with interstitial lung disease (ILD) and healthy volunteers. It aims to understand how ILD affects daily movement and overall fitness.
AnkaraAges 18–75 - NCT06949150Recruiting
Combined heart CT scan study for coronary artery disease
This study tests a new way to use CT scans to look at both the structure of your heart arteries and how well blood flows through them. It may help doctors get a more complete picture of coronary artery disease without extra procedures.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06949865Recruiting
AI-enhanced levodopa challenge test for parkinsonism
This study uses artificial intelligence (AI) to improve a standard test for parkinsonism called the levodopa challenge test. It may help doctors better understand how your movement symptoms respond to levodopa, a common Parkinson's medication.
BeijingAges 50–75 - NCT06950255Recruiting
Cane training for walking in Parkinson's disease
This study tests whether learning to use a simple cane can improve walking in people with Parkinson's disease. You will be trained to use a cane and then your walking will be measured.
Belo Horizonte, Minas GeraisAges 40 years+ - NCT06952348Recruiting
Stair climbing vs brisk walking for blood pressure
This study tests whether climbing stairs regularly can lower blood pressure better than brisk walking. It is for people who have high blood pressure, are overweight, and are not very active right now.
StockholmAges 35 years+ - NCT06952543Recruiting
Ultrasound blood flow test for leg artery disease
This study uses ultrasound to measure blood flow in the legs of people with PAD symptoms and healthy volunteers. It aims to improve how doctors assess peripheral arterial disease without invasive tests.
Rochester, MinnesotaAges 18–75 - NCT06955377Recruiting
Bending forward and airway protection in Parkinson's disease
This study looks at how bending forward (trunk flexion) affects your body's ability to protect your airway in Parkinson's disease. It may help understand breathing risks and guide therapy.
PragueAges 18 years+ - NCT06955624Recruiting
Sorting DNA changes to better diagnose nerve conditions
This study uses advanced DNA analysis to understand confusing genetic test results in people with brain or nerve diseases. It aims to improve diagnosis by reclassifying uncertain genetic findings.
RouenAges Any age - NCT06956027Recruiting
Ultrasound study of Dupuytren's disease nodules
This study uses ultrasound to look at Dupuytren's disease nodules and track changes over 6 months. It may help doctors understand which nodules are active and need treatment.
Leuven, Vlaams-BrabantAges Any age - NCT06956300Recruiting
TMS to help with thinking and memory in aging
This study uses a noninvasive brain stimulation technique called TMS to see if it can slow cognitive decline in older adults who are healthy or have very early signs of Alzheimer's disease. It aims to improve memory and thinking.
Boston, MassachusettsAges 40–99 - NCT06956742Recruiting
Breathing device study for COPD shortness of breath after exercise
This trial tests a device that briefly opens your airways to help release trapped air after exercise. It may reduce shortness of breath and improve your daily life with COPD.
Rouen, NormandyAges 18 years+ - NCT06957405Recruiting
Mental practice for freezing in Parkinson's disease
This trial tests whether remote mental practice can help reduce freezing of gait in people with Parkinson's disease. If you experience freezing episodes, you may be able to participate from home through video calls.
São Paulo, São PauloAges Any age - NCT06958536RecruitingPhase 2
Testing a new drug for moderate to severe Crohn's disease
This study tests an experimental drug called SAR442970 for people with moderate to severe Crohn's disease who haven't had success with standard treatments or biologics. The goal is to see if it can reduce inflammation and improve symptoms.
Tucson, ArizonaAges 18–75 - NCT06964269RecruitingPhase 4
Acthar Gel for dry eye and autoimmune disease
This trial tests a new injectable medicine, Acthar Gel, for moderate to severe dry eye and eye pain linked to autoimmune disease. It aims to see if the drug can relieve these symptoms safely.
Nashville, TennesseeAges 18–85 - NCT06965374Recruiting
Study of a new Parkinson's injection and quality of life
This study is looking at how a new continuous 24-hour injection treatment (foslevodopa/foscarbidopa) affects quality of life in people with advanced Parkinson's disease. It is a real-world study, meaning you just take the medication as your doctor prescribes, and researchers observe the results.
Troina, EnnaAges 18 years+ - NCT06971627Recruiting
Remote monitoring for inflammatory bowel disease
This trial tests if regular video check-ins via phone or computer can help people with IBD stick to their medications and feel better emotionally. You would use a messaging app and video calls to stay in touch with your care team from home.
IstanbulAges 18 years+ - NCT06971874Recruiting
Sleep apnea and kidney disease: A study on outcomes
This trial looks at how obstructive sleep apnea affects people with chronic kidney disease (stages 3-4). It aims to help understand the connection between these conditions and guide better care.
Guangzhou, GuangdongAges 18–75 - NCT06976203RecruitingPhase 3
Testing karxt for thinking problems in alzheimer's
This trial tests if a combination medicine, KarXT plus KarX-EC, can help with thinking and memory problems in people with mild to moderate Alzheimer's disease. It aims to see if the treatment is safe and effective.
Fullerton, CaliforniaAges 60–85 - NCT06976216RecruitingPhase 3
Study of KarXT plus KarX-EC for Alzheimer's cognitive symptoms
This trial tests a new combination treatment (KarXT plus KarX-EC) to see if it can help with thinking and memory problems caused by Alzheimer's disease. It is for people with mild to moderate Alzheimer's who have a caregiver available.
Long Beach, CaliforniaAges 60–85 - NCT06978647RecruitingPhase 1
YTS109 cell therapy for stubborn autoimmune diseases
This trial tests a new cell therapy called YTS109 for people with certain autoimmune diseases like lupus that have not improved with standard treatments. It aims to see if this therapy can help control disease activity.
Beijing, Beijing MunicipalityAges 18–65 - NCT06979284Recruiting
Ultrasound inside artery for severe leg blockages
This trial tests whether using a special ultrasound probe inside the artery (called intravascular ultrasound) helps guide treatment for people with severe leg artery blockages that cause pain, wounds, or gangrene. The goal is to see if it improves blood flow and saves the leg.
HamiltonAges 18 years+ - NCT06983964Recruiting
CAR-T cell therapy for autoimmune diseases that haven't improved
This trial tests a personalized cell therapy (CAR-T) that targets a protein called CD19 on immune cells. It's for people with certain autoimmune diseases like lupus or scleroderma that are still active despite standard treatments. The goal is to see if this therapy can help control the disease when other options haven't worked.
Beijing, Beijing MunicipalityAges 18–65 - NCT06984484Recruiting
Afluxin for GERD: safety and performance study
This trial tests a new treatment called Afluxin for people with gastroesophageal reflux disease (GERD), which causes heartburn and regurgitation. It aims to see if Afluxin is safe and works better than a placebo (inactive control) to relieve symptoms.
GenovaAges 18–75 - NCT06984549Recruiting
Dry eye detection via smartphone camera
This study tests if a smartphone can take clear pictures and videos of your eyes to help doctors check for dry eye disease. It may be a simpler way to evaluate dryness from home.
Wenzhou, ZhejiangAges 18 years+
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,561 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.